The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,183.00
Bid: 1,181.00
Ask: 1,182.00
Change: 22.50 (1.94%)
Spread: 1.00 (0.085%)
Open: 1,167.50
High: 1,183.50
Low: 1,162.50
Prev. Close: 1,160.50
SGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading and COVID-19 Update

6 Apr 2020 07:00

RNS Number : 8162I
Sage Group PLC
06 April 2020
 

Trading and COVID-19 update

6 April 2020

The Sage Group ("Sage" or the "Group") today issues an update on trading for the six months to 31 March 2020, and on the impact of the global COVID-19 pandemic on its business.

Group focus

Sage's response to the COVID-19 pandemic has been to ensure the health and wellbeing of our colleagues, to continue serving and supporting our customers, partners and accountants, and to remain focused on our SaaS transition strategy. Our business operations have continued with minimal disruption to date, thanks to the ongoing dedication and commitment of our colleagues, most of whom are now working from home. We have put in place a range of measures to help customers, including offering practical advice and quick access to expert support. The impact of COVID-19 remains highly uncertain, and we are closely monitoring developments in order to adapt our response accordingly.

Trading update for the six months to 31 March 2020

Growth in organic recurring revenue, which represents around 90% of Group sales, was ahead of full year guidance, supported by strong momentum in our core markets. Other revenue (SSRS and processing), representing around 10% of Group sales, declined in line with the Group's strategy, although the decrease accelerated towards the end of March as a result of COVID-19 impacting licence sales and professional services implementations.

COVID-19 future impact and outlook

Sage is a resilient business supported by high-quality recurring revenues and a diversified customer base of small and medium businesses. However, the sharp downturn in global economic activity caused by the spread of COVID-19 is expected to have a broad impact on businesses generally, and as a result Sage anticipates being affected in the following areas:

· customers deferring purchase decisions, leading to a slowdown in new customer acquisition, licence sales and professional services implementations; and

· a higher business failure rate leading to an increase in churn.

It is too early to quantify with confidence the impact on Sage's financial performance for the full financial year to 30 September. However the Board now believes it is likely that organic recurring revenue growth will be below the previously guided range of 8% to 9%, and that the decline in other revenue (SSRS and processing) will accelerate significantly in the second half, with some associated impact on margin. We will provide a further update at our interim results.

Sage has identified and is implementing a range of mitigating actions to manage costs and cash in the near-term, while continuing to invest in the long-term success of the business.

The Group remains confident in its strategy to transition to subscription and the cloud. The current disruption supports the adoption by businesses of cloud-based solutions that provide resilience and enable flexible working practices. Despite the near-term uncertainties, we believe our investment into Sage Business Cloud, together with our focus on customer and colleague success, leave Sage well-positioned for the longer-term SaaS opportunity.

Financial strength

The Group has a strong balance sheet, with approximately £1.3 billion of cash and available liquidity as at 31 March 2020. This includes around £900 million of cash and cash equivalents, and more than £400 million of undrawn facilities under the Group's Revolving Credit Facility which expires in February 2025. Net debt to EBITDA as at 31 March 2020 is expected to be well below 1.0x. Maturities within the next 18 months comprise $150 million (£121 million) of the Group's US private placement loan notes in May 2020, and the Group's £200 million syndicated Term Loan in September 2021.

To further support the Group's financial strength, the Board has now decided to cancel the £250 million share buy-back programme, which was suspended on 18 March 2020 after £6 million of shares had been purchased.

Interim results

The Group intends to publish its interim results on Wednesday 13 May 2020.

 

 

Enquiries

The Sage Group plc +44 (0) 191 294 3457

Jonathan Howell, CFO

James Sandford, VP Investor Relations

Amy Lawson, EVP Communications

 

FTI Consulting +44 (0) 20 3727 1000

Charles Palmer

Dwight Burden

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUVOWRRBUSRAR
Date   Source Headline
13th Feb 20236:16 pmRNSPublication of Final Terms
9th Feb 20239:32 amRNSDirector/PDMR Shareholding
7th Feb 20239:46 amRNSDirector/PDMR Shareholding
3rd Feb 202312:14 pmRNSDirector Declaration
2nd Feb 20233:31 pmRNSResult of AGM
2nd Feb 20239:57 amRNSDirector Declaration
31st Jan 20233:35 pmRNSSage: Publication of Base Prospectus
31st Jan 20233:00 pmRNSTotal Voting Rights
23rd Jan 20234:58 pmRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update for the 3 months ended 31 Dec 2022
30th Dec 202211:15 amRNSTotal Voting Rights
15th Dec 202211:21 amRNSDirector/PDMR Shareholding
8th Dec 20225:40 pmRNSDirector/PDMR Shareholding
8th Dec 20227:00 amRNSUpdate on financial reporting
7th Dec 20226:00 pmRNSDirector/PDMR Shareholding
7th Dec 202210:12 amRNSNotice of AGM
6th Dec 20226:13 pmRNSDirector/PDMR Shareholding
6th Dec 20225:23 pmRNSDirector/PDMR Shareholding
6th Dec 202210:25 amRNSBlock listing Interim Review
1st Dec 202211:03 amRNSAnnual Financial Report
30th Nov 20222:00 pmRNSTotal Voting Rights
24th Nov 202210:00 amRNSNon-executive Director Appointment
18th Nov 20229:13 amRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSResults for the year ended 30 September 2022
15th Nov 20227:00 amRNSNon-executive Director Appointment
31st Oct 20223:00 pmRNSTotal Voting Rights
30th Sep 202211:45 amRNSTotal Voting Rights
20th Sep 20227:00 amRNSInvestor and Analyst Event
31st Aug 20223:44 pmRNSTotal Voting Rights
30th Aug 20225:10 pmRNSSage completes Lockstep acquisition
24th Aug 20223:37 pmRNSDirector/PDMR Shareholding
18th Aug 202210:19 amRNSDirector/PDMR Shareholding
16th Aug 20227:00 amRNSSage to acquire Lockstep
2nd Aug 20227:00 amRNSTrading update for nine months ended 30 June 2022
29th Jul 20224:04 pmRNSTotal Voting Rights
22nd Jul 20229:02 amRNSDirectorate Change
30th Jun 20224:10 pmRNSTotal Voting Rights
24th Jun 20224:34 pmRNSDirector/PDMR Shareholding
16th Jun 20223:38 pmRNSDirector/PDMR Shareholding
8th Jun 20224:48 pmRNSDirector/PDMR Shareholding
8th Jun 20229:00 amRNSDirector Declaration
7th Jun 20222:53 pmRNSDirector/PDMR Shareholding
6th Jun 20222:00 pmRNSBlock listing Interim Review
31st May 20225:09 pmRNSTotal Voting Rights
25th May 20225:24 pmRNSDirector/PDMR Shareholding
19th May 20225:36 pmRNSDirector/PDMR Shareholding
19th May 20225:20 pmRNSDirector/PDMR Shareholding
13th May 20227:00 amRNSResults for the 6 months to 31 March 22 unaudited
29th Apr 20224:10 pmRNSTotal Voting Rights
31st Mar 20223:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.